| Zugriffe | |
|---|---|
| Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 509 |
| Oktober 2025 | November 2025 | Dezember 2025 | Januar 2026 | Februar 2026 | März 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in the treatment of Pneumocystis pneumonia | 29 | 16 | 13 | 20 | 12 | 14 | 5 |
| Zugriffe | |
|---|---|
| 3_Chapter3_Materials_Methods.pdf | 422 |
| 6_Chapter6_References.pdf | 324 |
| 0_Title_Index.pdf | 271 |
| 1_Chapter1_Introduction_aims_objectives.pdf | 243 |
| 7_Chapter7_Appendices_Aknowledgements.pdf | 223 |
| 4_Chapter4_Results_Discussions.pdf | 212 |
| 2_Chapter2_Literature_review.pdf | 188 |
| 5_Chapter5_Summary_Zusammenfassung.pdf | 128 |
